Vælg sprog

da
  • bg

  • cs

  • da

  • de

  • el

  • en

  • es

  • et

  • fr

  • hr

  • hu

  • it

  • lt

  • lv

  • nl

  • no

  • pl

  • pt

  • ro

  • ru

  • sk

  • sl

  • sv

  • tr

  • uk

Danske
  • Български

  • Čeština

  • Danske

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Hrvatski

  • Magyar

  • Italiano

  • Lietuvių

  • Latviešu

  • Nederlands

  • Norsk

  • Polski

  • Português

  • Română

  • Русский

  • Slovenský

  • Slovenski

  • Svenska

  • Türkçe

  • Українська

Hvordan foretrækker du at finansierer din konto?

* Vi opkræver ingen kommission for at foretage indbetalinger på din konto

McKesson Corporation 

MCK.US $ 253.23 USD

1.26 $ (0.51%)

Vækstpotentiale

Anbefaling
revideres

Udbytteindkomst

1.22%

1d
1u
1 måned
6 måneder
Hele tiden

Tilføj til kurv

1 lot = 1 aktie

Købsbeløb:

Mæglerkommission:

Overførselsgebyr:

Anbefaling

Neutral

Præstationsbedømmelse

DCF

285.71

ROE

216.14

ROA

-0.07

P/S

0.13

P/B

-1434.39

Debt / Equity

-393.95

Om virksomheden

The McKesson Corporation is the oldest American pharmaceutical company and the major medicine distributor in the US and Canada. The company was founded in 1833 in New York by Charles Olcott and John McKesson under the name of Olcott & McKesson. The company supplies a third of all medicines in North America. McKesson owns the Health Mart franchise network, which owns over 3,000 pharmacies. McKesson is also engaged in the development of software for electronic medical information card, data analysis, and hospital administration. Over half of the US hospitals and medical facilities employ its services. McKesson maintains active efforts in Canada, Australia, New Zealand as well as in many European countries. Now the company employs about 70 thousand people with the revenue as of 2017 by$ 142.2 billion. According to Fortune 500, McKesson is the 11th company in the by the world by income amount.


Tilmeld dig investeringsideer fra Freedom Finance-analytikere

Vi sender en e-mail en gang om ugen, der kun indeholder de mest relevante og vigtige oplysninger

Tillykke!

Nu vil du altid være opmærksom på, hvilke aktier der er mere rentable at investere i